Rapid Repigmentation of Vitiligo Using Tofacitinib Plus Low-Dose, Narrowband UV-B Phototherapy.

JAMA Dermatol

Department of Dermatology, Yale School of Medicine, Yale University, New Haven, Connecticut.

Published: March 2018

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamadermatol.2017.5778DOI Listing

Publication Analysis

Top Keywords

rapid repigmentation
4
repigmentation vitiligo
4
vitiligo tofacitinib
4
tofacitinib low-dose
4
low-dose narrowband
4
narrowband uv-b
4
uv-b phototherapy
4
rapid
1
vitiligo
1
tofacitinib
1

Similar Publications

Background: A 308 nm excimer light is an effective treatment for vitiligo, with fewer treatment times, rapid obvious effects, relatively complete pigment recovery, good patient compliance, and safe and effective treatment for children. The disadvantage of this treatment is that some patients have a plateau during which the skin lesion reduction rate slows down or stalls after multiple treatments.

Methods: Treatment data were collected from all vitiligo patients in the Dermatology Department, distinguishing between those who underwent 308 nm excimer light treatment alone and those who received a combination of 308 nm excimer light and 2940 erbium laser treatment.

View Article and Find Full Text PDF

The color of the gingiva is one of the gingival properties that affects soft tissue aesthetics and the general look of a smile. Demands for a pleasing smile that includes a healthy dentition and an aesthetically enhanced gingival component are rising. Melanocytes are the cells that are mostly found in the basal and suprabasal layers of the epithelium.

View Article and Find Full Text PDF
Article Synopsis
  • Vitiligo treatment is difficult, especially in stable cases that need surgical options; researchers modified noncultured epidermal cell suspension to improve results.
  • The study compared two methods for stable vitiligo: one using trypsinized cells with cryoblebbling, and the other with nontrypsinized cells mixed with plasma gel and dermabrasion.
  • Results showed that the plasma gel method led to faster healing and repigmentation, fewer complications, and was easier and cheaper compared to the cryobleb method.
View Article and Find Full Text PDF
Article Synopsis
  • - Vitiligo is an autoimmune skin disorder that causes loss of pigment, and new treatments like Janus Kinase inhibitors are showing promise for managing it.
  • - A case study involving a 61-year-old man with resistant vitiligo showed significant improvement after using oral Abrocitinib, a JAK inhibitor, for 2 months after prior treatments plateaued.
  • - More research, including ongoing clinical trials, is essential to evaluate the long-term effectiveness and safety of these oral Janus Kinase inhibitors for treating vitiligo.
View Article and Find Full Text PDF

Alectinib induced vitiligo with rapid re-pigmentation.

Eur J Cancer

March 2024

Hospital for Skin Diseases, Shandong First Medical University, China; Shandong Provincial Institute of Dermatology and Venereology, Shandong Academy of Medical Sciences, China. Electronic address:

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!